| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |